India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
The little engine that keeps your body young: Mitochondria: How to keep them healthy? Although it is still a matter of research whether mitochondria are the main cause of aging , experts say that human behavior has been proven to affect their health. What is beneficial for these small parts of our cells, it benefits the entire body. Regular exercise has been proven to improve the functioning of mitochondria. In a very important study, researchers biopsied human thigh muscles. After an eight-week training program, they found more and healthier mitochondria in the muscle cells than before. Although both endurance and resistance training were effective for this, the greatest benefits were obtained when they were combined. Daria Mauchly-Rozen , a professor of chemical and systems biology at Stanford University and author of the book “ The Life Machines: How Taking Care of Your Mitochondria Can Transform Your Health ,” sheds light on this issue. “Exercise causes a little bit of dam...